Mesothelin-targeted second generation CAR-T cells inhibit growth of mesothelin-expressing tumors in vivo

Non-small cell lung cancer (NSCLC) and mesothelioma are renowned for being diagnosed at a late stage and poor prognosis. Although surgery, chemotherapy, and radiotherapy have yielded successful outcomes, the improvement on the survival rate of NSCLC and mesothelioma have been less marked. Recently,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Lin, Lou, Yuqing, Lu, Liming, Fan, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307389/
https://www.ncbi.nlm.nih.gov/pubmed/30651858
http://dx.doi.org/10.3892/etm.2018.7015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307389/
https://www.ncbi.nlm.nih.gov/pubmed/30651858
http://dx.doi.org/10.3892/etm.2018.7015

Ejemplares similares